Trisenox and electrocardiogram qt prolonged Patient Reports February 13, 2012

Trisenox Side Effects Report #5233337-7
Trisenox side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 76 years of age, weighting 187.0 lb, was diagnosed with myelodysplastic syndrome, iron overload and was treated with Trisenox. After drug was administered, patient experienced the following side effects: ascites, cardiac failure congestive, electrocardiogram qt prolonged, fluid overload, mitral valve incompetence, pleural effusion, pneumonia

, splenomegaly, tricuspid valve incompetence. Trisenox dosage: 0.25 MG/KG TWICE WEEKLY Q72HR INTRAVENOUS DRIP. During the same period patient was treated with EXJADE, THALIDOMIDE, ACYCLOVIR, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5853387-7
Trisenox side effect was reported by a Physician from ITALY on Sept 04, 2007. Female patient, 67 years of age, weighting 145.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, atrial fibrillation

, electrocardiogram qt prolonged, pleural effusion, pneumonia

, weight increased. Trisenox dosage: unknown. During the same period patient was treated with AXAGON, SYLORIC, RAMIPRIL, GLIBOMET, INSULINE NPH. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4728702-8
Trisenox side effect was reported by a Physician from UNITED STATES on July 07, 2005. Male patient, 71 years of age, weighting 218.0 lb, was diagnosed with multiple myeloma

and was treated with Trisenox. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood pressure decreased, electrocardiogram qt prolonged, eye disorder, loss of consciousness, pupil fixed, sinus bradycardia. Trisenox dosage: (0.25 MG/KG,Q3WK), IVI. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5536194-4
Trisenox side effect was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, 88 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, c-reactive protein increased, electrocardiogram qt prolonged, fluid retention, gamma-glutamyltransferase increased, hepatic function abnormal. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, POLYMYXIN B SULPHATE. Patient recovered.

Trisenox Side Effects Report #4840014-0
Trisenox side effect was reported by a Health Professional from JAPAN on Nov 11, 2005. Female patient, 88 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, hypoaesthesia, muscular weakness, neuropathy peripheral. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with MEXILETINE HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, VANCOMCYCIN HYDROCHLORIDE, CIPROFLOXACIN, AMPICILLIN, ARBEKACIN SULPHATE. Patient recovered.

Trisenox Side Effects Report #4867038-1
Trisenox side effect was reported by a Health Professional from JAPAN on Dec 14, 2005. Female patient, 88 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, neuropathy peripheral. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with MEXILETINE HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, CIPROFLOXACIN, AMPICILLIN, ARBEKACIN SULPHATE. Patient recovered.

Trisenox Side Effects Report #5768221-3
Trisenox side effect was reported by a Physician from JAPAN on May 26, 2008. Male patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, diarrhoea, electrocardiogram qt prolonged, hepatic function abnormal, hyperglycaemia, leukocytosis, pleural effusion, pneumonia

. Trisenox dosage: 8.4 MG DAILY INTRAVENOUS. During the same period patient was treated with GABAXATE MESILATE. Patient recovered.

Trisenox Side Effects Report #6073095-X
Trisenox side effect was reported by a Physician from JAPAN on Jan 28, 2009. Male patient, 85 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, leukocytosis, leukopenia. Trisenox dosage: 8.4 MG DAILY INTRAVENOUS. During the same period patient was treated with GABEXATE MESILATE. Patient recovered.

Trisenox Side Effects Report #5768567-9
Trisenox side effect was reported by a Health Professional from CANADA on May 28, 2008. Female patient, 84 years of age, was diagnosed with acute promyelocytic leukaemia, haematological malignancy, upper respiratory tract infection and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arrhythmia

, aspartate aminotransferase increased, atrial fibrillation

, blood lactic acid increased, blood potassium increased, cardiotoxicity, electrocardiogram qt prolonged, electrocardiogram st segment elevation. Trisenox dosage: 14 MG ONCE INTRAVENOUS DRIP. During the same period patient was treated with CIPRO, ATENOLOL, LORAZEPAM, DOCUSATE, FUROSEMIDE, POTASSIUM CHLORIDE, MAGNESIUM OXIDE. Patient died.

Trisenox Side Effects Report #5608248-5
Trisenox side effect was reported by a Physician from JAPAN on Jan 11, 2008. Male patient, 80 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, enterocolitis, hepatic function abnormal, pancytopenia, renal impairment. Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5671610-9
Trisenox side effect was reported by a Physician from JAPAN on Feb 29, 2008. Male patient, 80 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, enterocolitis, hepatic function abnormal, pancytopenia, renal impairment. Trisenox dosage: 8.25 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5270157-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, hepatic function abnormal, herpes zoster, liver disorder, rash

. Trisenox dosage: 8.0625MG. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #5320873-8
Trisenox side effect was reported by a Physician from JAPAN on Apr 23, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia, arrhythmia

and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, febrile neutropenia, herpes zoster, liver disorder, rash

. Trisenox dosage: 8.0625 MG DAILY. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #5309186-8
Trisenox side effect was reported by a Physician from JAPAN on Apr 09, 2007. Female patient, 77 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood lactate dehydrogenase increased, electrocardiogram qt prolonged, fibrin d dimer increased, gamma-glutamyltransferase increased, protein total decreased, white blood cell count decreased. Trisenox dosage: 9.315 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5081599-1
Trisenox side effect was reported by a Physician from JAPAN on July 27, 2006. Female patient, 77 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood lactate dehydrogenase increased, c-reactive protein increased, electrocardiogram qt prolonged, fibrin d dimer increased, gamma-glutamyltransferase increased, protein total decreased. Trisenox dosage: 9.315 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5325386-5
Trisenox side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, cerebral hypoperfusion, cerebral infarction, condition aggravated, dysarthria, dysphagia, electrocardiogram qt prolonged, haemodialysis, renal failure. Trisenox dosage: 10.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, GABEXATE MESILATE, CALCIUM GLUCONATE. Patient recovered.

Trisenox Side Effects Report #5354590-5
Trisenox side effect was reported by a Physician from JAPAN on June 04, 2007. Male patient, 73 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, brain stem infarction, dysphagia, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, haemodialysis. Trisenox dosage: 10.05 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, CALCIUM GLUCONATE. Patient recovered.

Trisenox Side Effects Report #5419968-X
Trisenox side effect was reported by a Physician from JAPAN on Aug 03, 2007. Male patient, 71 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac failure acute, electrocardiogram qt prolonged. Trisenox dosage: unknown. Patient died on 08/03/2007.

Trisenox Side Effects Report #5451966-2
Trisenox side effect was reported by a Physician from JAPAN on Aug 31, 2007. Male patient, 71 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cardiac failure acute, electrocardiogram qt prolonged, emphysema, extrasystoles. Trisenox dosage: 0.15 MG/KG QD INTRAVENOUS. During the same period patient was treated with POTASSIUM CHLORIDE, VALACYCLOVIR. Patient died on 08/03/2007.

Trisenox Side Effects Report #6078574-7
Trisenox side effect was reported by a Physician from JAPAN on Jan 30, 2009. Male patient, 71 years of age, weighting 125.9 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthma

, blood albumin decreased, blood pressure decreased, blood sodium increased, cardiac failure acute, cardio-respiratory arrest, electrocardiogram qt prolonged, emphysema. Trisenox dosage: 0.15 MG/KG QD INTRAVENOUS DRIP. During the same period patient was treated with POTASSIUM CHLORIDE, VALACYCLOVIR, POLYMYXIN B SULPHATE, ALLOPURINOL, ZOPICLONE, BENIDIPINE HYDROCHLORIDE. Patient died on 08/03/2007.

Trisenox Side Effects Report #5856707-2
Trisenox side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 70 years of age, weighting 158.7 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, decreased appetite, diarrhoea, electrocardiogram qt prolonged, nausea

, pancytopenia. Trisenox dosage: 10.627 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, POLAPREZINC, BROTIZOLAM. Patient recovered.

Trisenox Side Effects Report #5872002-X
Trisenox side effect was reported by a Physician from JAPAN on Aug 19, 2008. Male patient, 70 years of age, weighting 158.7 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, diarrhoea, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hepatic function abnormal, nausea

, pancytopenia. Trisenox dosage: 10.627 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, POLAPREZINC, BROTIZOLAM, FOSFLUCONAZOLE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5622337-0
Trisenox side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, electrocardiogram qt prolonged, lung disorder, respiratory failure. Trisenox dosage: 8.1 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DALTEPARIN, TRANEXAMIC ACID, FUROSEMIDE, POTASSIUM REPLACEMENT. Patient died on 01/02/2008.

Trisenox Side Effects Report #5912530-1
Trisenox side effect was reported by a Physician from JAPAN on Aug 05, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pericardial effusion, pleural effusion, ventricular tachycardia. Trisenox dosage: 12.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, LANATOSIDE C, HYDROCORTISONE SUCCINATE, FUROSEMIDE, ELECTROLYTE. Patient recovered.

Trisenox Side Effects Report #5959554-6
Trisenox side effect was reported by a Physician from JAPAN on Nov 06, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pericardial effusion, pleural effusion, ventricular tachycardia. Trisenox dosage: 12.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, LANATOSIDE C, HYDROCORTISONE SUCCINATE, FUROSEMIDE, ELECTROLYTE, ELECTORLYTE. Patient recovered.

Trisenox Side Effects Report #5976516-3
Trisenox side effect was reported by a Physician from JAPAN on Nov 12, 2008. Male patient, 68 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pericardial effusion, pleural effusion, ventricular tachycardia. Trisenox dosage: 12.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LANATOSIDE C, HYDROCORTISONE SUCCINATE, FUROSEMIDE, ELECTROLYTE. Patient recovered.

Trisenox Side Effects Report #5248065-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, catheter related infection, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, pathogen resistance, staphylococcal infection

. Trisenox dosage: 9.69 MG Q1D INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, METHYLPHENIDATE, ALPRAZOLAM, MILNACIPRAN HYDROCHLORIDE, AMIKACIN SULPHATE, PAROXETINE HYDROCHLORIDE. Patient recovered.

Trisenox Side Effects Report #5306139-0
Trisenox side effect was reported by a Physician from JAPAN on Apr 02, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE. Patient died on 01/19/2006.

Trisenox Side Effects Report #5390810-9
Trisenox side effect was reported by a Physician from JAPAN on July 06, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, catheter related infection, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal infection

. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, METHYLPHENIDATE, ALPRAZOLAM, MILNACIPRAN HYDROCHLORIDE, AMIKACIN SULPHATE, PAROXETINE HYDROCHLORIDE HYDRATE. Patient recovered.

Trisenox Side Effects Report #5393083-6
Trisenox side effect was reported by a Physician from JAPAN on June 27, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE HYDROCHLORIDE HYDRATE. Patient died on 01/19/2006.

Trisenox Side Effects Report #6065662-4
Trisenox side effect was reported by a Physician from JAPAN on Jan 19, 2009. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cytomegalovirus test positive, dialysis

, disease progression, electrocardiogram qt prolonged, hypokalaemia, hypomagnesaemia, intestinal obstruction, renal failure. Trisenox dosage: 5.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with POTASSIUM, MAGNESIUM. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #4569722-6
Trisenox side effect was reported by a Health Professional from on Dec 21, 2004. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: body temperature increased, disseminated intravascular coagulation, dyspnoea, electrocardiogram qt prolonged, leukocytosis, ventricular tachycardia. Trisenox dosage: 0.15MG/KG (QD), INTRAVENOUS. Patient recovered.

Trisenox Side Effects Report #4609440-9
Trisenox side effect was reported by a Health Professional from on Feb 21, 2005. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, electrocardiogram qt prolonged, retinoic acid syndrome, ventricular tachycardia. Trisenox dosage: 0.15MG/KG (QD), INTRAVENOUS. Patient recovered.

Trisenox Side Effects Report #5047198-2
Trisenox side effect was reported by a Physician from JAPAN on June 23, 2006. Male patient, 64 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased. Trisenox dosage: 8.76 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, IDARUBICIN, MEXILETINE HYDROCHLORIDE, GABEXATE MESILATE, AMIKACIN SULPHATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5987600-2
Trisenox side effect was reported by a Pharmacist from UNITED STATES on Aug 18, 2008. Male patient, 64 years of age, weighting 246.9 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, vision blurred. Trisenox dosage: 17 MG 1 MG/ML DAILY INTRAVENOUS DRIP. During the same period patient was treated with ASPIRIN, TOPROL, ZOFRAN, POTASSIUM CHLORIDE, SIMVASTATIN. Patient recovered.

Trisenox Side Effects Report #4701616-5
Trisenox side effect was reported by a Physician from on June 07, 2005. Male patient, 64 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, electrocardiogram qt prolonged. Trisenox dosage: 8.76 MG (8.76 MILLICURIES), IVI. During the same period patient was treated with MEXILETINE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4831873-6
Trisenox side effect was reported by a Physician from JAPAN on Nov 01, 2005. Male patient, 64 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged. Trisenox dosage: 8.76 MG QD INTRAVENOUS. During the same period patient was treated with MEXILETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4732834-8
Trisenox side effect was reported by a Physician from JAPAN on July 12, 2005. Male patient, 63 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: central nervous system lesion, condition aggravated, depressed level of consciousness, disseminated intravascular coagulation, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hypocalcaemia, hyponatraemia, leukocytosis. Trisenox dosage: unknown. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, ITRACONAZOLE, SULFAMETHOXAZOLE, DALTEPARIN, METHOTREXATE, CYTARABINE. Patient recovered.

Trisenox Side Effects Report #5136828-2
Trisenox side effect was reported by a Physician from JAPAN on Oct 05, 2006. Female patient, 62 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hepatic function abnormal, white blood cell count decreased. Trisenox dosage: 6.975 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5127284-9
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2006. Female patient, 61 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, c-reactive protein increased, condition aggravated, electrocardiogram qt prolonged, hepatic function abnormal, rash

, white blood cell count decreased. Trisenox dosage: 9.15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with SULFAMETHOXAZOLE, FLUCONAZOLE. Patient recovered.

Trisenox Side Effects Report #5518647-8
Trisenox side effect was reported by a Physician from JAPAN on Oct 29, 2007. Male patient, 61 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, multi-organ failure, ventricular tachycardia. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, TRETINOIN, GABEXATE MESILATE, CEFEPIME DIHYDROCHLORIDE, ITRACONAZOLE, DEXAMETHASONE PHOSPHATE. Patient was hospitalized. Patient died on 08/03/2007.

Trisenox Side Effects Report #4758956-3
Trisenox side effect was reported by a Health Professional from JAPAN on Aug 11, 2005. Male patient, 61 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: condition aggravated, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, pancytopenia. Trisenox dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM, ASCORBIC ACIDQ, CALCIUM PANTOTHENATE, DANAPAROID, GABEXATE MESILATE. Patient recovered.

Trisenox Side Effects Report #5136829-4
Trisenox side effect was reported by a Physician from JAPAN on Oct 05, 2006. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia, prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, herpes zoster, white blood cell count decreased. Trisenox dosage: 6.66 MG QD INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE. Patient recovered.

Trisenox Side Effects Report #5401990-0
Trisenox side effect was reported by a Physician from JAPAN on July 10, 2007. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain

, bone pain, disseminated intravascular coagulation, electrocardiogram qt prolonged, hypercalcaemia, hyperglycaemia, hyperkalaemia. Trisenox dosage: 7.5 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, NAFAMOSTAT MESILATE, GLUCOSE W, ELECTROLYTE, PARENTERAL FLUID OF HIGH, INSULIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5408384-2
Trisenox side effect was reported by a Physician from JAPAN on July 25, 2007. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back disorder, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone pain, disseminated intravascular coagulation, electrocardiogram qt prolonged, gamma-glutamyltransferase increased. Trisenox dosage: 7.245 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, NAFAMOSTAT MESILATE, GLUCOSE W, ELECTROLYTE, PARENTERAL FLUID OF HIGH, INSULIN. Patient recovered.

Trisenox Side Effects Report #5718737-0
Trisenox side effect was reported by a Physician from JAPAN on Apr 10, 2008. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, POTASSIUM SUPPLEMENT, GABEXATE MESILATE, CARPERITIDE, MICAFUNGIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5320867-2
Trisenox side effect was reported by a Physician from JAPAN on Apr 24, 2007. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, BROTIZOLAM, ETIZOLAM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5127285-0
Trisenox side effect was reported by a Physician from JAPAN on Sept 27, 2006. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, hepatic function abnormal, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5147069-7
Trisenox side effect was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 57 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, white blood cell count decreased. Trisenox dosage: 8.475 MG QD INTRAVENOUS DRIP. During the same period patient was treated with RANITIDINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN, SULFAMETHOXAZOLE, BROTIZOLAM, ETIZOLAM. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4701607-4
Trisenox side effect was reported by a Physician from on June 07, 2005. Female patient, 54 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood urea decreased, electrocardiogram qt prolonged, hyperglycaemia, pancytopenia, protein total decreased. Trisenox dosage: 5.67 MG (5.67 MG, QD), IVI. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5320868-4
Trisenox side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, ascites, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, neuropathy peripheral, pancytopenia, pleural effusion, respiratory failure, weight increased. Trisenox dosage: 8.25 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, FUROSEMIDE, DANAPAROID. Patient recovered.

Trisenox Side Effects Report #5133972-0
Trisenox side effect was reported by a Physician from JAPAN on Oct 02, 2006. Female patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, red blood cell count decreased, white blood cell count decreased. Trisenox dosage: 7.35 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5179503-0
Trisenox side effect was reported by a Physician from JAPAN on Nov 29, 2006. Female patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, red blood cell count decreased, white blood cell count decreased. Trisenox dosage: 7.35 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5635741-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 05, 2008. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia, convulsion prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blister, convulsion, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, meningitis

, pancytopenia, pseudomonas infection. Trisenox dosage: 10.425 MG,QD,INTRAVENOUS DRIP. During the same period patient was treated with VALPROATE, CYTARABINE, METHOTREXATE, PREDNISOLONE ACETATE, NAFAMOSTATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5643136-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia, convulsion prophylaxis and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, catheter site infection, central nervous system leukaemia, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, meningitis

, pancytopenia, pseudomonas infection. Trisenox dosage: 10.425 MG QD INTRAVENOUS DRIP. During the same period patient was treated with VALPROATE, CYTARABINE, METHOTREXATE, PREDNISOLONE ACETATE, NAFAMOSTATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5679663-9
Trisenox side effect was reported by a Physician from JAPAN on Mar 07, 2008. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, ascites, blood calcium decreased, blood fibrinogen increased, blood potassium decreased, electrocardiogram qt prolonged, fibrin degradation products increased, lung disorder, neuropathy peripheral. Trisenox dosage: 8.25 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FUROSEMIDE, IDARUBICIN, DANAPAROID, MEROPENEM TRIHYDRATE, CEFEPIME DIHYDROCHLORIDE, ISEPAMICIN SULPHATE, MICAFUNGIN. Patient recovered.

Trisenox Side Effects Report #5701451-5
Trisenox side effect was reported by a Health Professional from JAPAN on Mar 24, 2008. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, pancytopenia. Trisenox dosage: 10.095 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, METHOTREXATE, PREDNISOLONE. Patient recovered.

Trisenox Side Effects Report #5292474-1
Trisenox side effect was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, 51 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia, blood alkaline phosphatase increased, blood potassium decreased, blood urea increased, electrocardiogram qt prolonged, malaise, malignant neoplasm progression, renal impairment, sepsis

. Trisenox dosage: 9.165 MG QD INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN N, CEFTAZIDIME, MICAFUNGIN, IDARUBICIN, CYTARABINE, DALTEPARIN, ISEPAMICIN SULPHATE. Patient was hospitalized. Patient died on 04/18/2006.

Trisenox Side Effects Report #4855369-0
Trisenox side effect was reported by a Pharmacist from UNITED STATES on Dec 20, 2004. Male patient, 50 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged. Trisenox dosage: unknown. During the same period patient was treated with ONDANSETRON, ALLOPURINOL, SIMVASTATIN, METOPROLOL, EZETIMIDE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5844627-9
Trisenox side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, 49 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood cholesterol decreased, blood creatine phosphokinase decreased, blood sodium decreased, disseminated intravascular coagulation, electrocardiogram qt prolonged, hyperglycaemia. Trisenox dosage: 9.15 MG DAILY INTRAVENOUS DRIP. During the same period patient was treated with MAGNESIUM SULPHATE, CALCIUM, GABEXATE MESILATE, HYDROCORTISONE SUCCINATE, TOBRAMYCIN, CIPROFLOXACIN, MEROPENEM TRIHYDRATE, HALOPERIDOL. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5886835-7
Trisenox side effect was reported by a Physician from JAPAN on Sept 03, 2008. Male patient, 49 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood cholesterol decreased, blood creatine phosphokinase decreased, blood sodium decreased, disseminated intravascular coagulation, electrocardiogram qt prolonged, hyperglycaemia. Trisenox dosage: 9.15 MG DAILY INTRAVENOUS DRIP. During the same period patient was treated with MAGNESIUM SULPHATE, CALCIUM GLUCONATE, GABEXATE MESILATE, HYDROCORTISONE SUCCINATE, TOBRAMYCIN, CIPROFLOXACIN, MEROPENEM TRIHYDRATE, HALOPERIDOL. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #6121941-3
Trisenox side effect was reported by a Physician from JAPAN on Feb 26, 2009. Male patient, 48 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood cholesterol decreased, blood creatine phosphokinase decreased, blood sodium decreased, disseminated intravascular coagulation, electrocardiogram qt prolonged, hyperglycaemia. Trisenox dosage: unknown. During the same period patient was treated with MAGNESIUM SULPHATE, CALCIUM, GABEXATE MESILATE, HYDROCORTISONE SUCCINATE, TOBRAMYCIN, CIPROFLOXACIN, MEROPENEM, HALOPERIDOL. Patient was hospitalized. Patient died on 08/27/2007.

Trisenox Side Effects Report #6084441-5
Trisenox side effect was reported by a Physician from JAPAN on Feb 05, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, febrile neutropenia, leukocytosis, pleural effusion, renal impairment, respiratory disorder, sepsis

, septic shock. Trisenox dosage: 11 MG QD INTRAVENOUS DRIP. Patient died on 01/30/2009.

Trisenox Side Effects Report #6106670-4
Trisenox side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, febrile neutropenia, leukocytosis, neutrophil count decreased, pleural effusion, renal impairment, respiratory disorder, septic shock. Trisenox dosage: 11 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, IDARUBICIN HYDROCHLORIDE, ITRACONAZOLE, POTASSIUM CHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SENNOSIDE. Patient died on 01/30/2009.

Trisenox Side Effects Report #6108252-7
Trisenox side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, pleural effusion, respiratory disorder, septic shock, weight increased. Trisenox dosage: 11 MG QD INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, IDARUBICIN HYDROCHLORIDE, ITRACONAZOLE, POTASSIUM CHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LOXOPROFEN. Patient died on 01/30/2009.

Trisenox Side Effects Report #5114873-0
Trisenox side effect was reported by a Physician from JAPAN on Sept 05, 2006. Female patient, 43 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hepatic function abnormal, white blood cell count decreased. Trisenox dosage: 8.19 MG QD INTRAVENOUS DRIP. During the same period patient was treated with POTASSIUM CHLORIDE, TEPRENONE, MAGNESIUM OXIDE. Patient recovered.

Trisenox Side Effects Report #5913581-3
Trisenox side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient, 43 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, hepatic function abnormal, hyperglycaemia, ventricular extrasystoles, white blood cell count decreased. Trisenox dosage: 10.2 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4801568-3
Trisenox side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, ventricular extrasystoles. Trisenox dosage: 8.7 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #4806740-4
Trisenox side effect was reported by a Physician from JAPAN on Oct 12, 2005. Female patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, ventricular extrasystoles. Trisenox dosage: 8.7 MG QD INTRAVENOUS DRIP. Patient recovered.

Trisenox Side Effects Report #5556932-4
Trisenox side effect was reported by a Physician from JAPAN on Nov 26, 2007. Female patient, 38 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase decreased, blood magnesium decreased, blood potassium decreased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hepatic function abnormal, oedema, rash

. Trisenox dosage: 8.55 MG QD; INTRAVENOUS DRIP. During the same period patient was treated with GLYCYRRHIZIN, MAGNESIUM REPLACEMENT, POTASSIUM REPLACEMENT, HYDROCORTISONE SUCCINATE, PREDNISOLONE, SPIRONOLACTONE, FUROSEMIDE. Patient recovered.

Trisenox Side Effects Report #5635799-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 07, 2008. Female patient, 38 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood magnesium decreased, blood potassium decreased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hepatic function abnormal, oedema, rash

. Trisenox dosage: 8.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GLYCYRRHIZIN, MAGNESIUM REPLACEMENT, POTASSIUM REPLACEMENT, HYDROCORTISONE SUCCINATE, PREDNISOLONE, SPIRONOLACTONE, FUROSEMIDE. Patient recovered.

Trisenox Side Effects Report #4801211-3
Trisenox side effect was reported by a Physician from JAPAN on Sept 26, 2005. Female patient, 36 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: bacterial infection

, blood bilirubin increased, c-reactive protein increased, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, jaundice

, neutrophil count decreased, pyrexia, white blood cell count decreased. Trisenox dosage: 6.93 MG QD INTRAVENOUS DRIP. During the same period patient was treated with LACTOBACILLUS CASEI, LENOGRASTIM, CEFCAPENE PIVOXIL, GENTAMICIN, BUFEXAMAC. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5281885-6
Trisenox side effect was reported by a Physician from JAPAN on Mar 12, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hypokalaemia, pancytopenia. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CEFDINIR, ETIZOLAM, FEXOFENADINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, GEFARNATE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5336511-4
Trisenox side effect was reported by a Physician from JAPAN on May 14, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, electrocardiogram qt prolonged, hepatic function abnormal, protein total decreased, rash

, white blood cell count decreased. Trisenox dosage: 7.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5397292-1
Trisenox side effect was reported by a Physician from JAPAN on July 05, 2007. Female patient, 32 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, electrocardiogram qt prolonged, hepatic function abnormal, hypocalcaemia, pancytopenia. Trisenox dosage: 9.15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with FEXOFENADINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, GEFARNATE, ETIZOLAM, ZOLPIDEM TARTRATE. Patient recovered.

Trisenox Side Effects Report #5084862-3
Trisenox side effect was reported by a Physician from JAPAN on Aug 01, 2006. Male patient, 30 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, electrocardiogram qt prolonged, febrile neutropenia, white blood cell count decreased. Trisenox dosage: 8.43 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IMIPENEM CILASTATIN, BIFIDOBACTERIUM, LOPERAMIDE HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5574034-8
Trisenox side effect was reported by a Physician from JAPAN on Dec 14, 2007. Male patient, 28 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, haemoglobin decreased, tonsillitis. Trisenox dosage: 12 MG QD; INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, OMEPRAZOLE, ROXATIDINE ACETATE, FAMOTIDINE. Patient recovered.

Trisenox Side Effects Report #5580740-1
Trisenox side effect was reported by a Physician from JAPAN on Dec 06, 2007. Male patient, 28 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, haemoglobin decreased, hepatic function abnormal, tonsillitis. Trisenox dosage: 12 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, OMEPRAZOLE, ROXATIDINE ACETATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5639612-6
Trisenox side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 28 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, ventricular tachycardia. Trisenox dosage: 14 MG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5223699-9
Trisenox side effect was reported by a Physician from JAPAN on Jan 12, 2007. Female patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, ventricular extrasystoles. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #5497267-8
Trisenox side effect was reported by a Physician from JAPAN on Oct 10, 2007. Female patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, hypokalaemia, leukocytosis, platelet count decreased. Trisenox dosage: 7.8 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ELECTROLYTE, IDARUBICIN, PANIPENEM, AMIKACIN SULPHATE, MICAFUNGIN, ABREKACIN SULPHATE, MEROPENEM HYDRATE. Patient recovered.

Trisenox Side Effects Report #5525457-4
Trisenox side effect was reported by a Physician from JAPAN on Nov 05, 2007. Female patient, 27 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, haemoglobin decreased, hepatic function abnormal, hypokalaemia, leukocytosis, platelet count decreased. Trisenox dosage: 7.8 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, PANIPENEM, AMIKACIN SULPHATE, MICAFUNGIN, ARBEKACIN SULPHATE, MEROPENEM HYDRATE. Patient recovered.

Trisenox Side Effects Report #4837395-0
Trisenox side effect was reported by a Physician from JAPAN on Nov 08, 2005. Male patient, 24 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: delirium, depressed level of consciousness, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hypoaesthesia. Trisenox dosage: 0.15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, MICAFUNGIN, BIAPENEM, AMIKACIN SULPHATE, MIRIMOSTIM. Patient recovered.

Trisenox Side Effects Report #4924537-1
Trisenox side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 24 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood potassium decreased, delirium, depressed level of consciousness, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, hypoaesthesia, prothrombin time shortened. Trisenox dosage: 12.45 MG QD INTRAVENOUS DRIP. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, MICAFUNGIN, BIAPENEM, AMIKACIN SULPHATE, MIRIMOSTIM, ALLOPURINOL. Patient recovered.

Trisenox Side Effects Report #5987614-2
Trisenox side effect was reported by a Pharmacist from UNITED STATES on Jan 02, 2008. Male patient, 21 years of age, weighting 231.5 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: dysgeusia, electrocardiogram qt prolonged, tongue discolouration. Trisenox dosage: 15 MG QD INTRAVENOUS. During the same period patient was treated with ZOFRAN, ELECTROLYTE, MAALOX. Patient recovered.

Trisenox Side Effects Report #5391723-9
Trisenox side effect was reported by a Physician from JAPAN on July 10, 2007. Male patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: altered state of consciousness, blood creatinine increased, cerebral hypoperfusion, cerebral infarction, condition aggravated, dysarthria, dysphagia, electrocardiogram qt prolonged, haemodialysis. Trisenox dosage: 10.05 MG QD INTRAVENOUS DRIP. During the same period patient was treated with TRETINOIN, GABEXATE MESILATE, DALTEPARIN, GABEXATE MESILATE, CALCIUM GLUCONATE. Patient recovered.

Trisenox Side Effects Report #5507315-4
Trisenox side effect was reported by a Physician from JAPAN on Oct 22, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hepatic function abnormal, oedema, rash

, weight increased. Trisenox dosage: 8.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with HYDROCORTISONE SUCCINATE, PREDNISOLONE, SPIRONOLACTONE, FUROSEMIDE. Patient recovered.

Trisenox Side Effects Report #5592621-8
Trisenox side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, ventricular tachycardia. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #6012726-7
Trisenox side effect was reported by a Physician from JAPAN on Aug 08, 2008. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cytomegalovirus infection

, electrocardiogram qt prolonged, hypokalaemia, hypomagnesaemia, intestinal obstruction. Trisenox dosage: 5.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with POTASSIUM CHLORIDE, MAGNESIUM. Patient was hospitalized and became disabled. Patient recovered.

Trisenox Side Effects Report #4855376-8
Trisenox side effect was reported by a Health Professional from UNITED STATES on Sept 01, 2005. Male patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, renal failure. Trisenox dosage: 0.15 MG/KG QD INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5486497-7
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood potassium increased, blood pressure decreased, dialysis

, electrocardiogram qrs complex prolonged, electrocardiogram qt prolonged, electrocardiogram st segment elevation, tachycardia, ventricular extrasystoles. Trisenox dosage: 0.15 MG/KG ONCE INTRAVENOUS DRIP. During the same period patient was treated with INTERFERON, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5987613-0
Trisenox side effect was reported by a Health Professional from UNITED STATES on Feb 13, 2008. Female patient, 31 years of age, was treated with Trisenox. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, hepatic enzyme increased. Trisenox dosage: unknown. Patient recovered.

Trisenox Side Effects Report #5588255-1
Trisenox side effect was reported by a Physician from JAPAN on Dec 26, 2007. Female patient was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, enteritis, hepatic function abnormal, pancytopenia. Trisenox dosage: unknown. Patient recovered.

Trisenox and electrocardiogram qt prolonged

SideEffects101.com

Trisenox and electrocardiogram qt prolonged Patient Reports February 13, 2012

side effects of Trisenox